These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

675 related articles for article (PubMed ID: 15254015)

  • 21. Force impairment in calpain 3-deficient mice is not correlated with mechanical disruption.
    Fougerousse F; Gonin P; Durand M; Richard I; Raymackers JM
    Muscle Nerve; 2003 May; 27(5):616-23. PubMed ID: 12707983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Limb-girdle muscular dystrophy in the Netherlands: gene defect identified in half the families.
    van der Kooi AJ; Frankhuizen WS; Barth PG; Howeler CJ; Padberg GW; Spaans F; Wintzen AR; Wokke JH; van Ommen GJ; de Visser M; Bakker E; Ginjaar HB
    Neurology; 2007 Jun; 68(24):2125-8. PubMed ID: 17562833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sarcolemmal proteins and the spectrum of limb-girdle muscular dystrophies.
    Bönnemann CG; Finkel RS
    Semin Pediatr Neurol; 2002 Jun; 9(2):81-99. PubMed ID: 12139001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Limb-girdle muscular dystrophy: diagnostic evaluation, frequency and clues to pathogenesis.
    Lo HP; Cooper ST; Evesson FJ; Seto JT; Chiotis M; Tay V; Compton AG; Cairns AG; Corbett A; MacArthur DG; Yang N; Reardon K; North KN
    Neuromuscul Disord; 2008 Jan; 18(1):34-44. PubMed ID: 17897828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dysferlin mutations in LGMD2B, Miyoshi myopathy, and atypical dysferlinopathies.
    Nguyen K; Bassez G; Bernard R; Krahn M; Labelle V; Figarella-Branger D; Pouget J; Hammouda el H; Béroud C; Urtizberea A; Eymard B; Leturcq F; Lévy N
    Hum Mutat; 2005 Aug; 26(2):165. PubMed ID: 16010686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous dystrophin and dysferlin deficiencies associated with high-level expression of the coxsackie and adenovirus receptor in transgenic mice.
    Shaw CA; Larochelle N; Dudley RW; Lochmuller H; Danialou G; Petrof BJ; Karpati G; Holland PC; Nalbantoglu J
    Am J Pathol; 2006 Dec; 169(6):2148-60. PubMed ID: 17148677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterisation of the dysferlin skeletal muscle promoter.
    Foxton RM; Laval SH; Bushby KM
    Eur J Hum Genet; 2004 Feb; 12(2):127-31. PubMed ID: 14560310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. From T-tubule to sarcolemma: damage-induced dysferlin translocation in early myogenesis.
    Klinge L; Laval S; Keers S; Haldane F; Straub V; Barresi R; Bushby K
    FASEB J; 2007 Jun; 21(8):1768-76. PubMed ID: 17363620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A caveolin-3 mutant that causes limb girdle muscular dystrophy type 1C disrupts Src localization and activity and induces apoptosis in skeletal myotubes.
    Smythe GM; Eby JC; Disatnik MH; Rando TA
    J Cell Sci; 2003 Dec; 116(Pt 23):4739-49. PubMed ID: 14600260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysferlin expression in tubular aggregates: their possible relationship to endoplasmic reticulum stress.
    Ikezoe K; Furuya H; Ohyagi Y; Osoegawa M; Nishino I; Nonaka I; Kira J
    Acta Neuropathol; 2003 Jun; 105(6):603-9. PubMed ID: 12664320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein studies in dysferlinopathy patients using llama-derived antibody fragments selected by phage display.
    Huang Y; Verheesen P; Roussis A; Frankhuizen W; Ginjaar I; Haldane F; Laval S; Anderson LV; Verrips T; Frants RR; de Haard H; Bushby K; den Dunnen J; van der Maarel SM
    Eur J Hum Genet; 2005 Jun; 13(6):721-30. PubMed ID: 15827562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein and gene analyses of dysferlinopathy in a large group of Japanese muscular dystrophy patients.
    Tagawa K; Ogawa M; Kawabe K; Yamanaka G; Matsumura T; Goto K; Nonaka I; Nishino I; Hayashi YK
    J Neurol Sci; 2003 Jul; 211(1-2):23-8. PubMed ID: 12767493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel mechanism of myocyte degeneration involving the Ca2+-permeable growth factor-regulated channel.
    Iwata Y; Katanosaka Y; Arai Y; Komamura K; Miyatake K; Shigekawa M
    J Cell Biol; 2003 Jun; 161(5):957-67. PubMed ID: 12796481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aberrant dysferlin trafficking in cells lacking caveolin or expressing dystrophy mutants of caveolin-3.
    Hernández-Deviez DJ; Martin S; Laval SH; Lo HP; Cooper ST; North KN; Bushby K; Parton RG
    Hum Mol Genet; 2006 Jan; 15(1):129-42. PubMed ID: 16319126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid accumulation in dysferlin-deficient muscles.
    Grounds MD; Terrill JR; Radley-Crabb HG; Robertson T; Papadimitriou J; Spuler S; Shavlakadze T
    Am J Pathol; 2014 Jun; 184(6):1668-76. PubMed ID: 24685690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic manipulation of dysferlin expression in skeletal muscle: novel insights into muscular dystrophy.
    Millay DP; Maillet M; Roche JA; Sargent MA; McNally EM; Bloch RJ; Molkentin JD
    Am J Pathol; 2009 Nov; 175(5):1817-23. PubMed ID: 19834057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transgenic overexpression of caveolin-3 in the heart induces a cardiomyopathic phenotype.
    Aravamudan B; Volonte D; Ramani R; Gursoy E; Lisanti MP; London B; Galbiati F
    Hum Mol Genet; 2003 Nov; 12(21):2777-88. PubMed ID: 12966035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dysferlin protein analysis in limb-girdle muscular dystrophies.
    Vainzof M; Anderson LV; McNally EM; Davis DB; Faulkner G; Valle G; Moreira ES; Pavanello RC; Passos-Bueno MR; Zatz M
    J Mol Neurosci; 2001 Aug; 17(1):71-80. PubMed ID: 11665864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absence of T and B lymphocytes modulates dystrophic features in dysferlin deficient animal model.
    Farini A; Sitzia C; Navarro C; D'Antona G; Belicchi M; Parolini D; Del Fraro G; Razini P; Bottinelli R; Meregalli M; Torrente Y
    Exp Cell Res; 2012 Jun; 318(10):1160-74. PubMed ID: 22465227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteomic investigation of the molecular pathophysiology of dysferlinopathy.
    De Palma S; Morandi L; Mariani E; Begum S; Cerretelli P; Wait R; Gelfi C
    Proteomics; 2006 Jan; 6(1):379-85. PubMed ID: 16302276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.